Antibody-Drug Conjugates (ADCs) are a fundamental technology in modern tumor-targeted therapy with their ‘tripartite integrated design’ of ‘precision carrier - stable linker - potent payload’: The ...
Receptor mediated internalization is a key mechanism of action (MOA) for antibody drug conjugates (ADCs). However, current methods of studying antibody internalization have several limitations ...
Revvity has launched pHSense™ reagents, a plate-based technology designed to monitor receptor and antibody-drug conjugate (ADC) internalization in high-throughput workflows. The reagents use a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback